Dyne Therapeutics (NASDAQ:DYN) traded higher in the premarket on Wednesday after BMO Capital Markets launched its coverage with an Outperform recommendation and a $50 per share target, citing the ...

A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...

Bank of Montreal’s consistently bullish chief investment strategist isn’t blinking as U.S. President Donald Trump’s tariff ...

Investing.com -- BMO Capital Markets downgraded SolarEdge Technologies (NASDAQ:SEDG) to "Underperform" from "Market Perform" and set a price target of $15 given concerns over the sustainability of ...

Bank stocks are sure to be long-term winners in Canada, but these three look ultra promising for investors.

(Bloomberg) -- Bank of Montreal and Bank of Nova Scotia kicked off Canadian bank earnings season with strong results from their capital-markets divisions amid an increase in trading activity.

BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...

Canada's Bank of Nova Scotia and Bank of Montreal said on Tuesday they would wait for clarity on U.S. government tariffs to build more rainy-day reserves and take actions to manage risks.

BMO Capital initiated coverage of Rocket Pharmaceuticals (RCKT) with an Outperform rating and $50 price target The gene therapy company has “two major differences from the typical gene therapy ...